71 results
8-K
EX-1.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters … of the Commission thereunder.
(x) Taxes. The Company and its subsidiaries have paid all federal, state, local and foreign taxes and filed all tax returns
8-K
EX-4.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
of this Warrant shall be made without charge to the Holder for any issue or transfer tax, transfer agent fee or other incidental tax or expense (excluding any … , however, that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the registration of any
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
warrants
S-16
Material United States federal income tax consequences for investors in our common stock and pre-funded warrants
S-18
Underwriting
S-25 … warrants.
S-17
Material United States federal income tax consequences for investors in our common stock and pre-funded warrants
The following
424B5
NRIX
Nurix Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:06pm
Dividend policy
S-13
Dilution
S-14
Description of pre-funded warrants
S-16
Material United States federal income tax consequences for investors in our … , including any voting rights, until such pre-funded warrant holders exercise their pre-funded warrants.
S-17
Material United States federal income tax
8-K
EX-99.1
dqgejt3y0ou9nme2g
6 Oct 22
Nurix Therapeutics Reports Third Quarter Fiscal 2022 Financial Results and Provides a Corporate Update
4:10pm
8-K
EX-10.1
glhss
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-4.1
surbnum
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
424B5
lugr5aby t7xxt
8 Jul 22
Prospectus supplement for primary offering
4:10pm
424B5
5o5k 8o3c3pndx
8 Jul 22
Prospectus supplement for primary offering
4:09pm